High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up

References

• Barrier BF, Allison J, Hubbard GB, et al. Spontaneous adenomyosis in the chimpanzee (Pan troglodytes): a first report and review of the primate literature: case report. Hum Reprod. 2007;22(6):1714–1717.
   PubMed Web of Science ®Google Scholar
• Dueholm M. Transvaginal ultrasound for diagnosis of adenomyosis: a review. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):569–582.
   PubMed Web of Science ®Google Scholar
• Kim MD, Won JW, Lee DY, et al. Uterine artery embolization for adenomyosis without fibroids. Clin Radiol. 2004;59(6):520–526.
   PubMed Web of Science ®Google Scholar
• Lone FW, Balogun M, Khan KS. Adenomyosis: not such an elusive diagnosis any longer. J Obstet Gynaecol. 2006;26(3):225–228.
   PubMedGoogle Scholar
• Pinzauti S, Lazzeri L, Tosti C, et al. Transvaginal sonographic features of diffuse adenomyosis in 18–30-year-old nulligravid women without endometriosis: association with symptoms. Ultrasound Obstet Gynecol. 2015;46(6):730–736.
   PubMed Web of Science ®Google Scholar
• Naftalin J, Hoo W, Pateman K, et al. How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic. Hum Reprod. 2012;27(12):3432–3439.
   PubMed Web of Science ®Google Scholar
• Chapron C, Tosti C, Marcellin L, et al. Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes. Hum Reprod. 2017;32(7):1393–1401.
   PubMed Web of Science ®Google Scholar
• Garcia L, Isaacson K. Adenomyosis: review of the literature. J Minim Invas Gynecol. 2011;18(4):428–437.
   PubMed Web of Science ®Google Scholar
• Kwon YS, Roh HJ, Ahn JW, et al. Conservative adenomyomectomy with transient occlusion of uterine arteries for diffuse uterine adenomyosis. J Obstet Gynaecol Res. 2015;41(6):938–945.
   PubMed Web of Science ®Google Scholar
• Yeh CC, Su FH, Tzeng CR, et al. Women with adenomyosis are at higher risks of endometrial and thyroid cancers: a population-based historical cohort study. PLoS One. 2018;13(3):e0194011.
   PubMed Web of Science ®Google Scholar
• Di Spiezio Sardo A, Calagna G, Santangelo F, et al. The role of hysteroscopy in the diagnosis and treatment of adenomyosis. BioMed Res Int. 2017;2017:1.
   Web of Science ®Google Scholar
• Parazzini F, Mais V, Cipriani S, et al. Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy. Eur J Obstet Gynecol Reprod Biol. 2009;143(2):103–106.
   PubMed Web of Science ®Google Scholar
• Vannuccini S, Luisi S, Tosti C, et al. Role of medical therapy in the management of uterine adenomyosis. Fertil Steril. 2018;109(3):398–405.
   PubMed Web of Science ®Google Scholar
• Wood C. Surgical and medical treatment of adenomyosis. Hum Reprod Update. 1998;4(4):323–336.
   PubMed Web of Science ®Google Scholar
• Morelli M, Rocca ML, Venturella R, et al. Improvement in chronic pelvic pain after gonadotropin releasing hormone analogue (GnRH-a) administration in premenopausal women suffering from adenomyosis or endometriosis: a retrospective study. Gynecol Endocrinol. 2013;29(4):305–308.
   PubMed Web of Science ®Google Scholar
• Khan KN, Kitajima M, Hiraki K, et al. Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma. Hum Reprod. 2010;25(11):2878–2890.
   PubMed Web of Science ®Google Scholar
• Ishihara H, Kitawaki J, Kado N, et al. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas. Fertil Steril. 2003;79(Suppl 1):735–742.
   PubMed Web of Science ®Google Scholar
• Grow DR, Filer RB. Treatment of adenomyosis with long-term GnRH analogues: a case report. Obstet Gynecol. 1991;78(3 Pt 2):538–539.
   PubMed Web of Science ®Google Scholar
• Akira S, Mine K, Kuwabara Y, et al. Efficacy of long-term, low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for adenomyosis. Med Sci Monit: Int Med J Exp Clin Res. 2009;15(1):CR1–CR4.
   Google Scholar
• Zhang P, Song K, Li L, et al. Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis. Med Princ Pract. 2013;22(5):480–483.
   PubMed Web of Science ®Google Scholar
• Shaaban OM, Ali MK, Sabra AM, et al. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial. Contraception. 2015;92(4):301–307.
   PubMed Web of Science ®Google Scholar
• Bragheto AM, Caserta N, Bahamondes L, et al. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. Contraception. 2007;76(3):195–199.
   PubMed Web of Science ®Google Scholar
• Cho S, Nam A, Kim H, et al. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis. Am J Obstet Gynecol. 2008;198(4):373 e1–7.
   Web of Science ®Google Scholar
• Ozdegirmenci O, Kayikcioglu F, Akgul MA, et al. Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis. Fertil Steril. 2011;95(2):497–502.
   PubMed Web of Science ®Google Scholar
• Zheng J, Xia E, Li TC, et al. Comparison of combined transcervical resection of the endometrium and levonorgestrel-containing intrauterine system treatment versus levonorgestrel-containing intrauterine system treatment alone in women with adenomyosis: a prospective clinical trial. J Reprod Med. 2013;58(7–8):285–290.
   PubMed Web of Science ®Google Scholar
• Sheng J, Zhang WY, Zhang JP, et al. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception. 2009;79(3):189–193.
   PubMed Web of Science ®Google Scholar
• Dueholm M. Minimally invasive treatment of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2018;51:119–137.
   PubMed Web of Science ®Google Scholar
• Park DS, Kim ML, Song T, et al. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis. Taiwan J Obstet Gynecol. 2015;54(4):412–415.
   PubMed Web of Science ®Google Scholar
• Sequeiros RB, Joronen K, Komar G, et al. High intensity focused ultrasound (HIFU) in tumor therapy. Duodecim; laaketieteellinen aikakauskirja. 2017;133(2):143–149.
   PubMedGoogle Scholar
• Albisinni S, Melot C, Aoun F, et al. Focal treatment for unilateral prostate cancer using high-intensity focal ultrasound: a comprehensive study of pooled data. J Endourol. 2018;32(9):797.
   PubMed Web of Science ®Google Scholar
• Zhao H, Yang G, Wang D, et al. Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer. Anti-Cancer Drugs. 2010;21(4):447–452.
   PubMed Web of Science ®Google Scholar
• Ji Y, Hu K, Zhang Y, et al. High-intensity focused ultrasound (HIFU) treatment for uterine fibroids: a meta-analysis. Arch Gynecol Obstet. 2017;296(6):1181–1188.
   PubMed Web of Science ®Google Scholar
• Lang BHH, Woo YC, Chiu KW. Sequential high intensity focused ultrasound (HIFU) ablation in the treatment of benign multinodular goitre: an observational retrospective study. Eur Radiol. 2018;28(8):3237–3244.
   PubMed Web of Science ®Google Scholar
• Xiao J, Sun T, Zhang S, et al. HIFU, a noninvasive and effective treatment for chyluria: 15 years of experience. Surg Endosc. 2018;32(7):3064–3069.
   PubMed Web of Science ®Google Scholar
• Marinova M, Rauch M, Schild HH, et al. Novel non-invasive treatment with High-intensity Focused Ultrasound (HIFU). Ultraschall Med. 2016;37(1):46–55.
   PubMed Web of Science ®Google Scholar
• Cheung VY. Current status of high-intensity focused ultrasound for the management of uterine adenomyosis. Ultrasonography. 2017;36(2):95–102.
   PubMed Web of Science ®Google Scholar
• Feng Y, Hu L, Chen W, et al. Safety of ultrasound-guided high-intensity focused ultrasound ablation for diffuse adenomyosis: a retrospective cohort study. Ultrason Sonochem. 2017;36:139–145.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li K, Xie B, et al. Effective ablation therapy of adenomyosis with ultrasound-guided high-intensity focused ultrasound. Int J Gynaecol Obstet. 2014;124(3):207–211.
   PubMed Web of Science ®Google Scholar
• Yoon SW, Kim KA, Cha SH, et al. Successful use of magnetic resonance-guided focused ultrasound surgery to relieve symptoms in a patient with symptomatic focal adenomyosis. Fertil Steril. 2008;90(5): 2018 e13–5.
   Web of Science ®Google Scholar
• Fukunishi H, Funaki K, Sawada K, et al. Early results of magnetic resonance-guided focused ultrasound surgery of adenomyosis: analysis of 20 cases. J Minim Invas Gynecol. 2008;15(5):571–579.
   PubMed Web of Science ®Google Scholar
• Zhou M, Chen JY, Tang LD, et al. Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center. Fertil Steril. 2011;95(3):900–905.
   PubMed Web of Science ®Google Scholar
• Fan TY, Zhang L, Chen W, et al. Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis. Eur J Radiol. 2012;81(11):3624–3630.
   PubMed Web of Science ®Google Scholar
• Lee JS, Hong GY, Park BJ, et al. Ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroid & adenomyosis: a single center experience from the Republic of Korea. Ultrason Sonochem. 2015;27:682–687.
   PubMed Web of Science ®Google Scholar
• Guo Y, Duan H, Cheng J, et al. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study. BJOG. 2017;124 (Suppl 3):7–11.
   PubMed Web of Science ®Google Scholar
• Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. BJOG. 1990;97(8):734–739.
   Web of Science ®Google Scholar
• Ye MZ, Deng XL, Zhu XG, et al. [Clinical study of high intensity focused ultrasound ablation combined with GnRH-a and LNG-IUS for the treatment of adenomyosis]. Zhonghua fu chan ke za zhi. 2016;51(9):643–649.
   PubMedGoogle Scholar
• Hou Y, Qin Z, Fan K, et al. Combination therapeutic effects of high intensity focused ultrasound and Metformin for the treatment of adenomyosis. Exp Ther Med. 2018;15(2):2104–2108.
   PubMed Web of Science ®Google Scholar
• Shui L, Mao S, Wu Q, et al. High-intensity focused ultrasound (HIFU) for adenomyosis: two-year follow-up results. Ultrason Sonochem. 2015;27:677–681.
   PubMed Web of Science ®Google Scholar
• Guo Q, Xu F, Ding Z, et al. High intensity focused ultrasound treatment of adenomyosis: a comparative study. Int J Hyperthermia. 2018;35(1):505–509.
   PubMed Web of Science ®Google Scholar
• Yang X, Zhang X, Lin B, et al. Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis. Int J Hyperthermia. 2019;36(1):486–492.
   PubMed Web of Science ®Google Scholar
• Liu X, Wang W, Wang Y, et al. Clinical predictors of long-term success in ultrasound-guided high-intensity focused ultrasound ablation treatment for adenomyosis: a retrospective study. Medicine. 2016;95(3):e2443.
   PubMed Web of Science ®Google Scholar
• Krentel H, Cezar C, Becker S, et al. From clinical symptoms to MR imaging: diagnostic steps in adenomyosis. BioMed Res Int. 2017;2017:1.
   Web of Science ®Google Scholar